We developed a rat pilocarpine seizure/status epilepticus (SE) model, which closely resembles 1.6-2.0/LD50 soman exposure, to analyse the molecular mechanism of neuronal damage and to screen effective neuroprotectants against cholinergic agonist and chemical warfare nerve agent (CWNA) exposure. Rats implanted with radiotelemetry probes capable of recording electroencephalogram (EEG), electrocardiogram (ECG), temperature, and physical activity were treated with lithium chloride (5 mEq/kg, im), followed 24 h later by (ip) doses of pilocarpine hydrochloride. Based on radiotelemetry analysis, a dose of 240 mg/kg (ip) pilocarpine generated seizure/SE analogous to 1.6-2.0/LD50 of soman. The model was refined by reducing the peripheral convulsions without affecting the central nervous system (CNS) by administering methylscopolamine bromide (1 mg/kg, ip), an anti-cholinergic that does not cross the blood brain barrier. However, when methylscopolamine bromide was administered, a higher dose of pilocarpine (320 mg/kg, ip) was required to generate the equivalent seizure/SE. Histopathology data indicated that pilocarpine induces significant damage to the hippocampal region of the brain, with similar neuropathology to that of 1.6-2.0/LD50 soman exposure. There was a reduction in body temperature after the administration of pilocarpine, as observed in organophosphate (OP) nerve agents exposure. The heart-rate of pilocarpine-treated animals increased compared to the normal range. The pilocarpine seizure/SE model was also reproducible in the absence of lithium chloride. These results support that pilocarpine seizure/SE model is useful in studying the molecular mechanisms of neuropathology and screening neuroprotectants following cholinergic agonist and CWNA exposure.
Abdel-Rahman, A., Shetty, A. K. and Abou-Donia, M. B.2002: Acute exposure to sarin increases blood brain barrier permeability and induces neuropathological changes in the rat brain: dose response relationships. Neuroscience113, 721-741.
2.
Blanchet, G., Carpentier, P., Lallement, G. and Sentenac-Roumanou, H.1994: [Prevention and treatment of status epilepticus induced by soman]. Annales Pharmaceutiques Francaises52, 11-24.
3.
Cook, L. L. and Persinger, M. A.1998: ‘Subclinical’ dosages of lithium and pilocarpine that do not evoke overt seizures affect long-term spatial memory but not learning in rats. Perceptual and Motor Skills86, 1288-1290.
4.
de Groot, D. M., Bierman, E. P. and Bruijnzeel, P. L.et al.2001: Beneficial effects of TCP on soman intoxication in guinea pigs: seizures, brain damage and learning behaviour. Journal of Applied Toxicology21Suppl 1, S57-S65.
5.
DeLorenzo, R. A.2001: Exposed. Signs, symptoms and EMS management of nerve-agent poisoning. The Journal of Emergency Medical Services: JEMS26, 48-57.
6.
Frantik, E. and Horvath, M.1992: Integration of behavioral and neurophysiological approaches in neurotoxicology. Toxicology Letter64-65, 225-229.
7.
Garcia-Cairasco, N., Rossetti, F., Oliveira, J. A. and Furtado, M. A.2004: Neuroethological study of status epilepticus induced by systemic pilocarpine in Wistar audiogenic rats (WAR strain). Epilepsy Behaviour5, 455-463.
8.
Gordon, C. J. and Mack, C. M.2001: Diurnal variation in thermoregulatory response to chlorpyrifos and carbaryl in the rat. Toxicology169, 93-105.
9.
Gordon, C. J., Fogelson, L., Richards, J. and Highfill, J.1991: Relationship between cholinesterase inhibition and thermoregulation following exposure to diisopropyl fluoro-phosphate in the rat. Toxicology Letter59, 161-168.
10.
Klitgaard, H., Matagne, A., Vanneste-Goemaere, J. and Margineanu, D. G.2002: Pilocarpine-induced epileptogenesis in the rat: impact of initial duration of status epilepticus on electrophysiological and neuropathological alterations. Epilepsy Research51, 93-107.
11.
Lallement, G., Carpentier, P. and Collet, A.et al.1991a: Effects of soman-induced seizures on different extracellular amino acid levels and on glutamate uptake in rat hippocampus. Brain Research563, 234-240.
12.
Lallement, G., Carpentier, P. and Collet, A.et al.1991b: [Involvement of glutamatergic system of amygdala in generalized seizures induced by soman: comparison with the hippocampus]. CR Academy of Science III313, 421-426.
13.
Lallement, G., Pernot-Marino, I. and Foquin-Tarricone, A.et al.1994: Coadministration of atropine, NBQX and TCP against soman-induced seizures. Neuroreport5, 1113-1117.
14.
Lallement, G., Dorandeu, F. and Filliat, P.et al.1998: Medical management of organophosphate-induced seizures. Journal of Physiology Paris92, 369-373.
15.
Lallement, G., Baubichon, D. and Clarencon, D.et al.1999: Review of the value of gacyclidine (GK-11) as adjuvant medication to conventional treatments of organophosphate poisoning: primate experiments mimicking various scenarios of military or terrorist attack by soman. Neurotoxicology20, 675-684.
16.
Liu, Z., Gatt, A. and Werner, S. J.et al.1994: Long-term behavioral deficits following pilocarpine seizures in immature rats. Epilepsy Research19, 191-204.
17.
Lowenstein, D. H.1999: Status epilepticus: an overview of the clinical problem. Epilepsia40Suppl 1, S3-S8.
18.
McDonough, J. H., Jr., Clark, T. R. and Slone, T. W., Jr.et al.1998: Neural lesions in the rat and their relationship to EEG delta activity following seizures induced by the nerve agent soman. Neurotoxicology19, 381-391.
19.
McDonough, J. H., Jr., McMonagle, J. and Copeland, T.et al.1999: Comparative evaluation of benzodiazepines for control of soman-induced seizures. Archives of Toxicology73, 473-478.
20.
McDonough, J. H., Jr. and Shih, T. M.1997: Neuropharmaco-logical mechanisms of nerve agent-induced seizure and neuropathology. Neuroscience and Biobehavioral Reviews21, 559-579.
21.
McDonough, J. H., Jr., Zoeffel, L. D. and McMonagle, J.et al.2000: Anticonvulsant treatment of nerve agent seizures: anticholinergics versus diazepam in soman-intoxicated guinea pigs. Epilepsy Research38, 1-14.
22.
Mejias-Aponte, C. A., Jimenez-Rivera, C. A. and Segarra, A. C.2002: Sex differences in models of temporal lobe epilepsy: role of testosterone. Brain Research944, 210-218.
23.
Moser, V. C., Becking, G. C. and Cuomo, V.et al.1997a: The IPCS collaborative study on neurobehavioral screening methods: III. Results of proficiency studies. Steering Group. Neurotoxicology18, 139-146.
24.
Moser, V. C., Tilson, H. A. and MacPhail, R. C.et al.1997b: The IPCS collaborative study on neurobehavioral screening methods: II. Protocol design and testing procedures. Neurotoxicology18, 929-938.
25.
Pazdernik, T. L., Emerson, M. R. and Cross, R.et al.2001: Soman-induced seizures: limbic activity, oxidative stress and neuroprotective proteins. Journal of Applied Toxicology21Suppl 1, S87-S94.
26.
Persinger, M. A., Bureau, Y. R. and Kostakos, M.et al.: Behaviors of rats with insidious, multifocal brain damage induced by seizures following single peripheral injections of lithium and pilocarpine. Physiol Behav53, 849-866.
27.
Savolainen, K. M., Nelson, S. R., Samson, F. E. and Pazdernik, T. L.1988: Soman-induced convulsions affect the inositol lipid signaling system: potentiation by lithium; attenuation by atropine and diazepam. Toxicology and Applied Pharmacology96, 305-314.
28.
Savolainen, K. M., Muona, O. and Nelson, S. R.et al.1991: Lithium modifies convulsions and brain phosphoinositide turnover induced by organophosphates. Pharmacology and Toxicology68, 346-354.
29.
Shih, T. M. and McDonough, J. H., Jr.1997a: Neurochemical mechanisms of nerve agent-induced seizure and neuro-pathology. Neurosci Biobehav Rev21, 559-579.
30.
Shih, T. M. and McDonough, J. H., Jr.1997b: Neurochemical mechanisms in soman-induced seizures. Journal of Applied Toxicology17, 255-264.
31.
Shih, T. M. and McDonough, J. H., Jr.1999: Organophosphorus nerve agents-induced seizures and efficacy of atropine sulfate as anticonvulsant treatment. Pharmacology and Biochemical Behavior64, 147-153.
32.
Shih, T. M. and McDonough, J. H.2000: Efficacy of biperiden and atropine as anticonvulsant treatment for organophosphorus nerve agent intoxication. Archives of Toxicology74, 165-172.
33.
Shih, T. M., Duniho, S. M. and McDonough, J. H.2003: Control of nerve agent-induced seizures is critical for neuroprotection and survival small star, filled. Toxicology and Applied Pharmacology188, 69-80.
34.
Terry, J. B., Padzernik, T. L. and Nelson, S. R.1990: Effect of LiCl pretreatment on cholinomimetic-induced seizures and seizure-induced brain edema in rats. Neuroscience Letter114, 123-127.
35.
Turski, W. A., Cavalheiro, E. A. and Schwarz, M.et al.1983: Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study. Behavioral Brain Research9, 315-335.
36.
Turski, L., Cavalheiro, E. A. and Sieklucka-Dziuba, M.et al.1986: Seizures produced by pilocarpine: neuropathological sequelae and activity of glutamate decarboxylase in the rat forebrain. Brain Research398, 37-48.
37.
van Helden, H. P. and Bueters, T. J.1999: Protective activity of adenosine receptor agonists in the treatment of organophosphate poisoning. Trends in Pharmacological Science20, 438-441.
38.
Worek, F., Kleine, A., Falke, K. and Szinicz, L.1995: Arrhythmias in organophosphate poisoning: effect of atropine and bispyridinium oximes. Archives of Internal Pharmacodynamic Therapy329, 418-425.
